AllianceBernstein’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.8M Sell
45,982
-15,489
-25% -$1.62M ﹤0.01% 1497
2025
Q1
$7.17M Buy
61,471
+14,881
+32% +$1.74M ﹤0.01% 1309
2024
Q4
$3.94M Sell
46,590
-78,388
-63% -$6.63M ﹤0.01% 1596
2024
Q3
$11.2M Sell
124,978
-43,784
-26% -$3.93M ﹤0.01% 1126
2024
Q2
$13.6M Buy
168,762
+88,608
+111% +$7.13M ﹤0.01% 1020
2024
Q1
$6.4M Buy
80,154
+38,864
+94% +$3.1M ﹤0.01% 1375
2023
Q4
$3.29M Hold
41,290
﹤0.01% 1682
2023
Q3
$2.89M Buy
41,290
+590
+1% +$41.2K ﹤0.01% 1680
2023
Q2
$2.92M Hold
40,700
﹤0.01% 1688
2023
Q1
$2.51M Hold
40,700
﹤0.01% 1739
2022
Q4
$3.14M Hold
40,700
﹤0.01% 1653
2022
Q3
$1.82M Hold
40,700
﹤0.01% 1946
2022
Q2
$1.56M Buy
40,700
+700
+2% +$26.8K ﹤0.01% 2094
2022
Q1
$1.66M Buy
40,000
+3,400
+9% +$141K ﹤0.01% 2191
2021
Q4
$1.38M Sell
36,600
-4,200
-10% -$159K ﹤0.01% 2335
2021
Q3
$1.35M Hold
40,800
﹤0.01% 2371
2021
Q2
$2.75M Sell
40,800
-599,585
-94% -$40.4M ﹤0.01% 1976
2021
Q1
$36.3M Buy
640,385
+42,587
+7% +$2.41M 0.02% 713
2020
Q4
$48.7M Buy
597,798
+55,525
+10% +$4.52M 0.02% 591
2020
Q3
$38.6M Buy
542,273
+86,071
+19% +$6.13M 0.02% 608
2020
Q2
$37.5M Buy
456,202
+156,411
+52% +$12.9M 0.02% 599
2020
Q1
$17.6M Buy
299,791
+31,966
+12% +$1.88M 0.01% 724
2019
Q4
$27.7M Sell
267,825
-498,354
-65% -$51.5M 0.02% 708
2019
Q3
$15.5M Sell
766,179
-4,691
-0.6% -$94.9K 0.01% 879
2019
Q2
$19.9M Buy
+770,870
New +$19.9M 0.01% 805